Project Grant RF1AG088003

Award Date 9/22/24
Completion Date 8/31/27
Dollars Obligated $2.4M
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21218, USA
Similar Awards
This federal Project Grant award, totaling $4,444,978.00, was provided by the National Institute on Aging (NIH) under the Aging Research program (CFDA 93.866) to study the determinants of cognitive reserve in older adults with and without formal education in India. The overarching goal is to identify modifiable factors, such as employment, social relationships, and social engagement, that may promote cognitive reserve and reduce the risk of Alzheimer's disease and related dementias (ADRD) in...
This Project Grant award, valued at $12,847,914, was provided by the National Institute on Aging (CFDA 93.866 - Aging Research) to Emory University. The goal of this 5-year project is to characterize genetic, socio-behavioral, and vascular risk factors associated with the Alzheimer's disease (AD) continuum in the middle-aged South Asian population in India. Key activities include: 1) Performing multimodal AD phenotyping and genetic characterization across the disease continuum; 2)...
This federal Project Grant award, funded by the National Institute on Aging under the Aging Research program (CFDA 93.866), totals $2,451,044 and is titled "Engaging Aging Minds: Labor Force Participation, Stimulating Activities, and Cognitive Aging Across Diverse International Settings." The project aims to investigate the impact of labor force participation and stimulating activities in middle and later life on cognitive aging outcomes across culturally diverse populations, including...
The federal Project Grant award R01AG082056 for $1,199,134 was made by the National Institute on Aging (NIA) under the Aging Research Federal Grant Program (CFDA 93.866). The award supports a study on the "Social Epigenetics of Alzheimer's Disease and Related Dementias in Latin American Countries (LAC)". The primary awardee is Weill Medical College of Cornell University, which has established sub-awards with Universidad Adolfo Ibanez (Chile), Pontificia Universidad Javeriana...
This $622,401 project grant award from the National Institute on Aging's Aging Research Federal Grant Program (CFDA 93.866) supports a multi-year research effort at the University of Southern California to develop advanced artificial intelligence models for analyzing neuroimaging data and identifying modifiable lifestyle factors that influence the progression of Alzheimer's disease and related dementias (ADRD). The key objectives of the project are to: 1) use deep learning and event-based...
This Project Grant award from the National Institute on Aging (NIA) under CFDA 93.866 - Aging Research provides $2,288,327 to the University of California, San Diego (UCSD) to investigate early determinants of Alzheimer's disease (AD) using age-equivalent neurons derived from mild cognitive impairment (MCI) patients. The research aims to better understand the intersection of polygenic risk factors, biological aging, and key molecular pathways that initiate and drive MCI, with the goal of...
This federal Project Grant award, funded by the National Institute on Aging (CFDA 93.866 - Aging Research), aims to establish the feasibility of leveraging Pakistan's high rate of consanguineous marriages to uncover the genomic architecture of Alzheimer's disease. The overall funding amount is $223,902, awarded from September 2024 to June 2026. The key products and services to be delivered under this grant include: Harmonizing data acquisition protocols with the NIA-funded Longitudinal Aging...
This federal Project Grant award of $778,551 from the National Institute on Aging's Aging Research program (CFDA 93.866) will fund a research project to estimate a novel probabilistic dementia classification for over 10 million Medicare beneficiaries aged 65 and older. The objective is to better understand diagnostic disparities in Alzheimer's disease and related dementias, particularly among racial/ethnic minority and underserved rural populations. The project will leverage linked Health and...
The National Institute on Aging (NIA) awarded a $2,288,528 Project Grant (CFDA 93.866 Aging Research) to The Trustees of Columbia University in the City of New York to study mild cognitive impairment (MCI) and Alzheimer's disease and related dementias (ADRD) from a cross-national perspective. The primary objectives are to: 1) harmonize MCI and dementia classifications across the U.S., Mexico, and India to compare longitudinal prognosis; 2) investigate sociodemographic, lifestyle, health, and...
This $287,118 Project Grant was awarded on September 1, 2023 by the National Institute on Aging (NIA) under the Aging Research (CFDA 93.866) grant program. The grant will fund the development of techniques to use deep transfer learning and multimodal data, including brain MRIs, genetic information, and cognitive tests, to enable the early detection and forecasting of Alzheimer's disease progression. The University of Massachusetts (UMass), as the prime awardee, will create an end-to-end...

This Project Grant award, with a total funding amount of $2,365,042, was provided by the National Institute on Aging under the Aging Research federal grant program (CFDA 93.866) to conduct a cross-national evaluation of the biological underpinnings of Alzheimer's disease and related dementias (ADRD) between the United States and India. The primary objective is to leverage harmonized data on neurodegenerative biomarkers, cognitive outcomes, and other physiological markers to better understand the interplay between biology, social factors, and ADRD risk and progression. The project involves multiple sub-awards to institutions including the University of Southern California, University of Minnesota, and University of California, Los Angeles to support tasks such as biomarker data development, MRI data analysis, and cross-national comparisons of biomarker-cognition associations and the moderating effects of socioeconomic factors. The award commenced on September 22, 2024 and is scheduled for completion by August 31, 2027.

Generated 5/13/25, 3:32 AM